Europe — EMA
Nytyka (Nintedanib)
Nintedanib, the active ingredient in Nytyka, is a tyrosine kinase inhibitor presented as a unknown/unknown for oral use. It treats fibrotic lung diseases such as idiopathic pulmonary fibrosis and is used in adult…
Request sourcing
What is Nintedanib?
Nintedanib, the active ingredient in Nytyka, is a tyrosine kinase inhibitor presented as a unknown/unknown for oral use. It treats fibrotic lung diseases such as idiopathic pulmonary fibrosis and is used in adult patients. GNH USA supplies Nytyka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Nytyka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals …
What is Nintedanib used for?
Nytyka (nintedanib) acts .... - ... .... … .... .... .... ... …
